City

Houston (1)

Condition

Stage IIB Esophageal Cancer AJCC v7 (2)

Stage IIIA Esophageal Cancer AJCC v7 (2)

Stage IIIB Esophageal Cancer AJCC v7 (2)

Stage IIIC Esophageal Cancer AJCC v7 (2)

Gastroesophageal Junction Adenocarcinoma (1)

Malignant Neoplasm of the Cervical Esophagus (1)

Malignant Neoplasm of the Thoracic Esophagus (1)

Stage IIA Esophageal Cancer AJCC v7 (1)

Stage III Esophageal Cancer AJCC v7 (1)

Overall Status

Completed (1)

Withdrawn (1)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

Sponsor

M.D. Anderson Cancer Center (1)

OHSU Knight Cancer Institute (1)

Collaborator

National Cancer Institute (NCI) (1)

Oregon Health and Science University (1)

Intervention

carboplatin (1)

ferumoxytol (1)

ganetespib (1)

magnetic resonance imaging (1)

paclitaxel (1)

radiation therapy (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

radiation (1)

Funder Type

Other (2)

Study Type

Interventional (2)

stage iib esophageal cancer ajcc v7

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Stage IIB Esophageal Cancer AJCC v7, Stage III Esophageal Cancer AJCC v7, Stage IIIA Esophageal Cancer AJCC v7 Trial

Withdrawn

Stage IIB Esophageal Cancer AJCC v7
+4 more

Ferumoxytol
Magnetic Resonance Imaging

(no location specified)

Sep 8, 2021

Gastroesophageal Junction Adenocarcinoma, Malignant Tumor of the Cervical Esophagus, Malignant Tumor of the Thoracic Esophagus

Completed

Gastroesophageal Junction Adenocarcinoma
+7 more

Carboplatin
+3 more

Houston, Texas

M D Anderson Cancer Center

Jul 22, 2019